IRD trials box
Category: Autre
mise à jour avec succès: 2 févr. 2020
Auteurs
Created byJason Comander
Attachments
Les événements
Vitamin A/E for
Retinitis PigmentosaOmega-3 (DHA) for
Retinitis PigmentosaLutein for Retinitis
PigmentosaSafety and Dose Escalation Study of
AAV2-hCHM in Subjects With CHM
(Choroideremia) Gene MutationsSafety and Efficacy of
rAAV-hRS1in Patients With
X-linked Retinoschisis (XLRS)Safety and Tolerability of
hRPC in Retinitis PigmentosaSafety and Efficacy Trial of AAV
Gene Therapy in Patients
With CNGA3 AchromatopsiaRate of Progression in USH2A Related
Retinal Degeneration (RUSH 2A)Safety and Efficacy Trial of AAV
Gene Therapy in Patients
With CNGB3 AchromatopsiaGene Therapy for X-linked RP (RPGR)Ocular Genomics
Institute createdAAV platform technology enters
in strategic partnership with LonzaOdylia Therapeutics is foundedFirst post-approval gene therapy
procedure for an inherited
disease (voretigene/RPE65)First DNA mutation identified for
an inherited retinal degenerationFounding of Berman-Gund
Laboratory & RP FoundationA Safety Study of Retinal Gene
Therapy for Choroideremia (GEMINI)Single Ascending Dose Study in
Participants With LCA10 (CEP290 / CRISPR)
Comments